• 300+

    industry experts
  • 120

    MDs, PhDs, PharmDs
  • 650+

    product launches

ICON's integrated team of 300+ access, commercialisation and communications experts provides life-science clients with guidance and workable solutions to support global brand success. Our cross-functional experts are unparalleled in their ability to accelerate, demonstrate, and communicate the value of your product to drive payer acceptance and patient access.

  • Combining highly trained scientific minds with commercial and medical affairs strategists to address challenges in rapidly growing market segments
  • Over 120 MD’s, PhD’s & Pharm D’s on staff
  • Expertise in orthopaedics, rare disease, immunology, oncology, neurology/CNS, metabolic disease
  • Delivering the combined expertise of market-leading consulting practices aligned to client stakeholder groups
  • Over 70 product launches in the last five years and 650+ products total
  • In-house digital and creative agency

Services to support global brand success

Combining scientific analysis and assessment with commercial research and insights, we deliver an integrated scientific and market access roadmap for your pharmaceutical or medical device product. Our broad range of insights generation, strategic planning, and tactical services include:  

  • Pricing: product pricing, market specific payer considerations and commercial forecasting
  • Clinical trial planning: evidence requirements and clinical trial protocol optimisation 
  • Economic modelling: demonstrating value of healthcare products in major European, Asian and North American markets
  • HTA services: reimbursement submission planning, analysis, development, and engagement
  • Value messaging: development, testing, and communications
  • Dossier development: global/core and AMCP 
  • Literature reviews: systematic, targeted, and network meta-analysis
  • Stakeholder insights generation and engagement: payer, government, healthcare professional, and patient
  • Publications: scientific and HEOR publication and medical affairs strategy 
  • Launch execution: training, contracting, and customer engagement and pull-through
  • Creative and digital design: Dedicated creative, digital and analytics teams support client engagement 

Helping you to understand how payers and providers think

ICON gives you easy access to clinical and reimbursement decision makers around the world.  Our relationships with principal investigators, study collaborators, authors, and clinical research institutions are highly beneficial and allow you insights from the world’s most influential KOLs.

In the US, we publish P&T Community and Managed Care, two of the leading US managed care trade publications, with a combined circulation of more than 136,000.

Our proprietary ACCESS LINE™ and Medical Directors Forum™ gives us direct access to more than 7,000 hard-to-reach US population health, hospital, specialty pharmacy, and health plan decision makers.

Outside of the US, we work with an established global advisory network of more than 1,000 HTA, payer, and health system decision makers in core mature and English-speaking secondary markets (EU5, UK, Canada, Australia).

We collaborate with trusted alliance partners to assist in our research in non-English speaking and emerging markets.

Our comprehensive strategic consulting approach begins with scientific analysis and assessment, leverages research to generate key insights, forms those insights into strategy, and supports the implementation of strategy with tactical development and creative execution.

To speak with an expert, contact us today.